GRFS | Grifols sa - Stock Value & PE Ratio Analysis

3

24

15

Excellent Growth

AI analysis rates GRFS with the highest value score of 5.
It is mainly due to adequate operating cash flow, along with stable company liquidity.
Over the past 3 months, GRFS has maintained a consecutive value rating of 5.0, slightly higher than the rating of 4.1 over the past 3 years, indicating continued upward trend in enterprise value.
Compared to all stocks in the Health Care sector, GRFS has a higher value rating.

GRFS Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/03/20 (Weekly Update)

GRFS Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

GRFS Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.26	85.7%	100%	2.06B	5.7%	7.1%	2.9%
2024Q2	0.16	45.5%	-27.3%	1.97B	16.7%	-3.1%	0.8%
2024Q1	0.02	-94.3%	-91.3%	1.95B	21.9%	4%	1.3%
2023Q4	0.07	-75.9%	-53.3%	1.75B	8.8%	-10.7%	3.2%
2023Q3	0.14	-62.2%	-36.4%	1.95B	22.5%	1.6%	3.7%

Update to 2025/5/9 (Quarterly Update)

GRFS Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

GRFS Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of GRFS from 2011/06 till Now

-72.04%
Cumulative Return: -8.76%
Annual Return: 32.34%
Volatility: -0.27
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from June, 2011 to May, 2025. (Total Trades: 4)